WST up +3.12% percent right now. $WST High is at 52.00 and the Low 50.50 with current volume of 443,687.
Recent News posted below.
WST West Pharmaceutical Services Recent Headline News
West Receives 510(k) Clearance for NovaGuard(TM) SA Safety System
PR Newswire - Tue Nov 11, 7:00AM CST
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the NovaGuard SA (Staked-needle Automatic) safety system has received 510(k) clearance from the United States Food and Drug Administration. The NovaGuard SA safety system helps reduce the risk of needlestick injuries by shielding the exposed needle of a prefilled syringe after use.
WST: 51.90 (+1.56)
Shares of WST Up 20.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Nov 05, 9:43AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 3 months, West Pharmaceutical Services has returned 20.37% as of today's recent price of $51.12.
WST: 51.90 (+1.56)
West Pharmaceuticals: A Little Giant In The Pharma Sector
Bill Gunderson - Seeking Alpha - Mon Nov 03, 9:26AM CST
West Pharmaceutical Services ( WST ) is an example of a good stock in a good sector. I like the health care sector in the current market environment but I prefer companies that are growing at a faster pace than the Eli Lillys ( LLY ) and Mercks ( ...
WST: 51.90 (+1.56), MRK: 59.49 (+0.68), LLY: 68.21 (-0.14)
West Pharmaceutical Services Larger Than S&P 500 Component Allegheny Technologies
TheOnlineInvestor.com - Thu Oct 30, 3:43PM CDT
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component West Pharmaceutical Services, Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example Allegheny...
WST: 51.90 (+1.56)
West Pharmaceutical Services' (WST) CEO Don Morel on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 12:27PM CDT
WST: 51.90 (+1.56)
West Pharmaceutical Services (WST) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 7:55AM CDT
WST: 51.90 (+1.56)
West Pharmaceutical beats by $0.01, revenue in-line
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 6:16AM CDT
WST: 51.90 (+1.56)
West Pharmaceutical posts 3Q profit
Automated Insights - Thu Oct 30, 6:10AM CDT
LIONVILLE, Pa. (AP) _ West Pharmaceutical Services Inc. (WST) on Thursday reported net income of $31 million in its third quarter.
WST: 51.90 (+1.56)
West Announces Third Quarter 2014 Results
Marketwired - Thu Oct 30, 6:02AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2014 and updated its revenue and gross margin guidance for 2014 and its long-term financial objectives.
WST: 51.90 (+1.56)
West Pharmaceutical Services Shares Up 13.0% Since SmarTrend's Buy Recommendation (WST)
Comtex SmarTrend(R) - Wed Oct 29, 9:23AM CDT
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 2 months, West Pharmaceutical Services has returned 12.97% as of today's recent price of $47.98.
WST: 51.90 (+1.56)
West Pharmaceuticals In Q3: The Cure For What Ails You?
Kurt Avard - at Seeking Alpha - Tue Oct 28, 12:38PM CDT
WST: 51.90 (+1.56)
The Week Ahead In Earnings Reports: Pharmaceuticals
Kurt Avard - at Seeking Alpha - Sat Oct 25, 4:32PM CDT
WST: 51.90 (+1.56), PFE: 30.26 (+0.06), MRK: 59.49 (+0.68)
West Pharma Services reports October 30
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 12:22PM CDT
WST: 51.90 (+1.56)
West to Host Third Quarter 2014 Conference Call
Marketwired - Thu Oct 23, 7:01AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today that it will release third quarter 2014 financial results before the market opens on Thursday, October 30, 2014 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-280-4960 (U.S.) or 857-244-7317 (International). The passcode is 46283848.
WST: 51.90 (+1.56)
West's Vial2Bag DC Device Receives U.S. FDA 510(k) Clearance and CE Mark
PR Newswire - Tue Oct 21, 7:00AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has received 510(k) clearance of the Vial2Bag® DC device from the United States Food and Drug Administration, and also the CE Mark for the European Union.
WST: 51.90 (+1.56)
Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Monday: GAIN, GOOD, WST
at The Street - Fri Oct 17, 9:03AM CDT
GAIN GOOD WST are going ex-dividend Monday, Monday, October 20, 2014
WST: 51.90 (+1.56), GOOD: 18.08 (-0.09), GAIN: 7.31 (-0.04)
West Pharmaceutical CEO to retire next year
AP - Wed Oct 15, 8:50AM CDT
NEW YORK (AP) — West Pharmaceutical Services Inc. said Wednesday that its longtime CEO Donald Morel plans to retire in May. The company, which makes syringes, medicine vials and other medical products, also narrowed its earnings outlook for the year.
WST: 51.90 (+1.56)
West Pharma chief to retire
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 8:45AM CDT
WST: 51.90 (+1.56)
West Pharmaceutical Services Announces CEO Retirement and Succession Plan
PR Newswire - Wed Oct 15, 7:22AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative drug packaging and administration systems, said today that Donald E. Morel, Jr., Ph.D., Chairman of the Board and Chief Executive Officer, has announced his intention to retire at the Company's Annual Meeting in May 2015. The West Board of Directors has retained Russell Reynolds Associates, a leading executive search firm, to launch a comprehensive search to identify Dr. Morel's successor.
WST: 51.90 (+1.56)
Global Pharmaceutical Packaging Market Outlook 2019: Key Players in the $86 Billion Industry are Amcor, CCL Industries, Intrapac, Rexam Plc and Schott AG
M2 - Mon Oct 13, 5:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cbs5dv/global) has announced the addition of the "Global Pharmaceutical Packaging Market - By Primary Packaging Material, Type Of Packaging, Geography And Vendors - Forecasts, Trends And Shares (2014- 2019)" report to their offering. The pharmaceutical packaging market is expected to grow at a CAGR of 8.38% to reach $86.7 billion by the end of 2019 from the current estimates of $57.9 billion. Some of the major vendors are Amcor, CCL Industries, Intrapac, Rexam Plc and Schott AG. Pharmaceutical industry is seeing an exponential growth. With changing lifestyle, more and more people are being diagnosed with various diseases. With increased spending on healthcare by government of different countries world over, pharmaceutical has become a multi-billion dollar industry. Pharmaceutical manufacturers must follow stringent requirements to protect consumer safety and environmental regulations. Increasing cost pressures on pharmaceutical manufacturers is forcing them to pass on this cost on to packaging companies which has become a driving force of pharmaceutical packaging market. The rise in self-medication and over the counter products is also contributing to growth of this industry. It is necessary for packaging companies to manufacture such packages which meet the objectives of keeping the product safe from environment and vice versa. Also there should be proper labelling of the products so that, it cannot be counterfeited and it should have a longer shelf life. Some of the pharmaceutical packaging products being used to meet above objectives are ampoule, vial, dropper bottle, labels and patient information booklet. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Insights 4. Technology Overview 5. Pharmaceutical Packaging Market by Primary Packaging Material 6. Pharmaceutical Packaging Market Segmentation by Type of Packaging 7. Pharmaceutical Packaging Market Segmentation by Region 8. Competitive Intelligence and Investment Analysis 9. Vendor Profiles 10. Future of Pharmaceutical Packaging Market Companies Mentioned - Amcor - Aptargroup - CCL Industries - Gerresheimer AG - Intrapac - Klockner Pentaplast - Meadwestvaco Corporation - Rexam Plc - Schott AG - West Pharmaceutical Services - Wihuri Group For more information visit http://www.researchandmarkets.com/research/cbs5dv/global
WST: 51.90 (+1.56)
Recent News posted below.
WST West Pharmaceutical Services Recent Headline News
West Receives 510(k) Clearance for NovaGuard(TM) SA Safety System
PR Newswire - Tue Nov 11, 7:00AM CST
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the NovaGuard SA (Staked-needle Automatic) safety system has received 510(k) clearance from the United States Food and Drug Administration. The NovaGuard SA safety system helps reduce the risk of needlestick injuries by shielding the exposed needle of a prefilled syringe after use.
WST: 51.90 (+1.56)
Shares of WST Up 20.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Nov 05, 9:43AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 3 months, West Pharmaceutical Services has returned 20.37% as of today's recent price of $51.12.
WST: 51.90 (+1.56)
West Pharmaceuticals: A Little Giant In The Pharma Sector
Bill Gunderson - Seeking Alpha - Mon Nov 03, 9:26AM CST
West Pharmaceutical Services ( WST ) is an example of a good stock in a good sector. I like the health care sector in the current market environment but I prefer companies that are growing at a faster pace than the Eli Lillys ( LLY ) and Mercks ( ...
WST: 51.90 (+1.56), MRK: 59.49 (+0.68), LLY: 68.21 (-0.14)
West Pharmaceutical Services Larger Than S&P 500 Component Allegheny Technologies
TheOnlineInvestor.com - Thu Oct 30, 3:43PM CDT
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component West Pharmaceutical Services, Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example Allegheny...
WST: 51.90 (+1.56)
West Pharmaceutical Services' (WST) CEO Don Morel on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 12:27PM CDT
WST: 51.90 (+1.56)
West Pharmaceutical Services (WST) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 7:55AM CDT
WST: 51.90 (+1.56)
West Pharmaceutical beats by $0.01, revenue in-line
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 6:16AM CDT
WST: 51.90 (+1.56)
West Pharmaceutical posts 3Q profit
Automated Insights - Thu Oct 30, 6:10AM CDT
LIONVILLE, Pa. (AP) _ West Pharmaceutical Services Inc. (WST) on Thursday reported net income of $31 million in its third quarter.
WST: 51.90 (+1.56)
West Announces Third Quarter 2014 Results
Marketwired - Thu Oct 30, 6:02AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2014 and updated its revenue and gross margin guidance for 2014 and its long-term financial objectives.
WST: 51.90 (+1.56)
West Pharmaceutical Services Shares Up 13.0% Since SmarTrend's Buy Recommendation (WST)
Comtex SmarTrend(R) - Wed Oct 29, 9:23AM CDT
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 2 months, West Pharmaceutical Services has returned 12.97% as of today's recent price of $47.98.
WST: 51.90 (+1.56)
West Pharmaceuticals In Q3: The Cure For What Ails You?
Kurt Avard - at Seeking Alpha - Tue Oct 28, 12:38PM CDT
WST: 51.90 (+1.56)
The Week Ahead In Earnings Reports: Pharmaceuticals
Kurt Avard - at Seeking Alpha - Sat Oct 25, 4:32PM CDT
WST: 51.90 (+1.56), PFE: 30.26 (+0.06), MRK: 59.49 (+0.68)
West Pharma Services reports October 30
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 12:22PM CDT
WST: 51.90 (+1.56)
West to Host Third Quarter 2014 Conference Call
Marketwired - Thu Oct 23, 7:01AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today that it will release third quarter 2014 financial results before the market opens on Thursday, October 30, 2014 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-280-4960 (U.S.) or 857-244-7317 (International). The passcode is 46283848.
WST: 51.90 (+1.56)
West's Vial2Bag DC Device Receives U.S. FDA 510(k) Clearance and CE Mark
PR Newswire - Tue Oct 21, 7:00AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has received 510(k) clearance of the Vial2Bag® DC device from the United States Food and Drug Administration, and also the CE Mark for the European Union.
WST: 51.90 (+1.56)
Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Monday: GAIN, GOOD, WST
at The Street - Fri Oct 17, 9:03AM CDT
GAIN GOOD WST are going ex-dividend Monday, Monday, October 20, 2014
WST: 51.90 (+1.56), GOOD: 18.08 (-0.09), GAIN: 7.31 (-0.04)
West Pharmaceutical CEO to retire next year
AP - Wed Oct 15, 8:50AM CDT
NEW YORK (AP) — West Pharmaceutical Services Inc. said Wednesday that its longtime CEO Donald Morel plans to retire in May. The company, which makes syringes, medicine vials and other medical products, also narrowed its earnings outlook for the year.
WST: 51.90 (+1.56)
West Pharma chief to retire
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 8:45AM CDT
WST: 51.90 (+1.56)
West Pharmaceutical Services Announces CEO Retirement and Succession Plan
PR Newswire - Wed Oct 15, 7:22AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative drug packaging and administration systems, said today that Donald E. Morel, Jr., Ph.D., Chairman of the Board and Chief Executive Officer, has announced his intention to retire at the Company's Annual Meeting in May 2015. The West Board of Directors has retained Russell Reynolds Associates, a leading executive search firm, to launch a comprehensive search to identify Dr. Morel's successor.
WST: 51.90 (+1.56)
Global Pharmaceutical Packaging Market Outlook 2019: Key Players in the $86 Billion Industry are Amcor, CCL Industries, Intrapac, Rexam Plc and Schott AG
M2 - Mon Oct 13, 5:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cbs5dv/global) has announced the addition of the "Global Pharmaceutical Packaging Market - By Primary Packaging Material, Type Of Packaging, Geography And Vendors - Forecasts, Trends And Shares (2014- 2019)" report to their offering. The pharmaceutical packaging market is expected to grow at a CAGR of 8.38% to reach $86.7 billion by the end of 2019 from the current estimates of $57.9 billion. Some of the major vendors are Amcor, CCL Industries, Intrapac, Rexam Plc and Schott AG. Pharmaceutical industry is seeing an exponential growth. With changing lifestyle, more and more people are being diagnosed with various diseases. With increased spending on healthcare by government of different countries world over, pharmaceutical has become a multi-billion dollar industry. Pharmaceutical manufacturers must follow stringent requirements to protect consumer safety and environmental regulations. Increasing cost pressures on pharmaceutical manufacturers is forcing them to pass on this cost on to packaging companies which has become a driving force of pharmaceutical packaging market. The rise in self-medication and over the counter products is also contributing to growth of this industry. It is necessary for packaging companies to manufacture such packages which meet the objectives of keeping the product safe from environment and vice versa. Also there should be proper labelling of the products so that, it cannot be counterfeited and it should have a longer shelf life. Some of the pharmaceutical packaging products being used to meet above objectives are ampoule, vial, dropper bottle, labels and patient information booklet. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Insights 4. Technology Overview 5. Pharmaceutical Packaging Market by Primary Packaging Material 6. Pharmaceutical Packaging Market Segmentation by Type of Packaging 7. Pharmaceutical Packaging Market Segmentation by Region 8. Competitive Intelligence and Investment Analysis 9. Vendor Profiles 10. Future of Pharmaceutical Packaging Market Companies Mentioned - Amcor - Aptargroup - CCL Industries - Gerresheimer AG - Intrapac - Klockner Pentaplast - Meadwestvaco Corporation - Rexam Plc - Schott AG - West Pharmaceutical Services - Wihuri Group For more information visit http://www.researchandmarkets.com/research/cbs5dv/global
WST: 51.90 (+1.56)
